IREN >$4B ARR target delayed to January 2027
Company: IREN
The claim, verbatim
IREN's target of more than $4 billion in fully contracted, fully funded annualized run-rate revenue moved from year-end 2026 to January 2027, and could extend to the end of February 2027. Management attributed the delay to a customer-requested design change and supplier timing.
Source (primary)
IREN slips as investors weigh delayed ARR milestone and fresh analyst resets - Quiver Quantitative (-, news_article)
View cached copy (2026-11-13)Live source ↗Archive.org ↗
Quote: “the more than $4 billion ARR target is now aimed for January 2027 and could extend to the end of February”
How we checked this
Checked on November 14, 2026. The cited source supports every part of this claim.
The article says management moved the fully contracted, fully funded ARR target of more than $4 billion from year-end 2026 to January 2027, possibly the end of February. It attributes the delay to a customer-requested design change and supplier timing.
Confirmed in the source:
- IREN's target is more than $4 billion in fully contracted, fully funded annualized revenue (ARR)
- The target was previously set for year-end 2026
- The target is now aimed for January 2027
- The target could extend to the end of February 2027
- Management attributed the timing shift to a customer-requested design change and supplier timing
What we did: Read our cached copy of the publisher (https://www.quiverquant.com/news/IREN+slips+as+investors+weigh+delayed+ARR+milestone+and+fresh+analyst+resets) in full (7,046 characters, retrieved November 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms IREN slips as investors weigh delayed ARR milestone and fresh analyst resets - Quiver Quantitative
Quote: “the more than $4 billion ARR target is now aimed for January 2027 and could extend to the end of February”